Telesis Bio, Inc.
TBIO
$0.42
$0.1240.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.52% | -- | 22.32% | -117.50% | 13.67% |
| Total Depreciation and Amortization | -13.27% | -- | 3.16% | 31.39% | 20.16% |
| Total Amortization of Deferred Charges | -93.17% | -- | -44.33% | -27.72% | 209.62% |
| Total Other Non-Cash Items | -55.63% | -- | -13.15% | 790.65% | 30.36% |
| Change in Net Operating Assets | -260.42% | -- | 254.64% | -7,741.18% | 124.27% |
| Cash from Operations | -18.51% | -- | 71.01% | -29.67% | 61.12% |
| Capital Expenditure | 25.68% | -- | -6.81% | 66.97% | 81.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 119.44% | -- | 177.60% | -43.64% | -257.79% |
| Cash from Investing | 119.14% | -- | 197.07% | -42.06% | -269.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -45,545.45% | -- | 36.67% | -83,522.22% | 99.93% |
| Issuance of Common Stock | -100.00% | -- | -66.67% | -78.91% | 525.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -608.70% | -- | -- | -4,661.90% | 84.27% |
| Cash from Financing | -66.34% | -- | -50.00% | -14,008.33% | -102.52% |
| Foreign Exchange rate Adjustments | 125.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.84% | -- | 227.13% | -378.71% | -1,209.07% |
